ArticleBMC gastroenterology2026
Preoperative clinical-imaging nomogram for peritoneal metastasis in gastric cancer: a retrospective cohort study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the preoperative predictive factors for peritoneal metastasis in patients with advanced gastric cancer and construct a nomogram prediction model combining clinical and radiomics features.
methodsA total of 342 patients with advanced gastric cancer who were scheduled to undergo surgical treatment were selected and randomly divided into a training set (239 cases) and a validation set (103 cases) at a ratio of 7:3. In the training set, patients were divided into a peritoneal metastasis group and a non-peritoneal metastasis group according to whether peritoneal metastasis was confirmed by postoperative pathology. Preoperative clinical data, laboratory indicators, CT imaging features, and radiomics features of patients were collected. A prediction model was constructed through multivariate logistic regression analysis, and the model’s efficacy was evaluated by receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA).
resultsAmong the 342 patients with advanced gastric cancer, 96 cases (40.17%) in the training set and 32 cases (31.07%) in the validation set had peritoneal metastasis. Multivariate logistic regression analysis showed that the maximum depth of ascites, the difference in omentum CT value, the longest diameter of the largest peritoneal nodule, tumor volume, tumor texture [Gray-level co-occurrence matrix (GLCM) contrast], and CA125 were independent predictive factors for peritoneal metastasis in advanced gastric cancer (all P < 0.05). The area under of ROC curves of the constructed nomogram model for predicting peritoneal metastasis in advanced gastric cancer were 0.852 (95% CI: 0.793–0.911) and 0.811 (95% CI: 0.712–0.910) in the training set and the validation set, respectively. The calibration curve showed good consistency between the predicted values and the actual observed values, and the P-values of the Hosmer-Lemeshow test were all > 0.05. DCA showed that the model had significant clinical net benefit within the threshold probability range of 0.1–0.8.
conclusionThe nomogram prediction model for peritoneal metastasis in advanced gastric cancer based on preoperative clinical-radiomics features has good predictive efficacy and clinical practicability, which can provide a reference for preoperative individualized risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.